1. Elea
  2. Dipartimenti e Centri di ricerca UniSA. Pubblicazioni scientifiche
  3. Translational Medicine @ UniSa
  4. Translational Medicine @ UniSa. Vol.4 (sept.-dec. 2012)
Please use this identifier to cite or link to this item: http://elea.unisa.it/xmlui/handle/10556/639
Abstract: Nuclear factor B (NFB) is a transcription factor that plays an important role in carcinogenesis as well as in the regulation of inflammatory response. NFB is constitutively expressed in tumours where it induces the expression of genes which promote cell proliferation, apoptotic events, angiogenesis, invasion and metastasis. Furthermore, many cancer cells show aberrant or constitutive NFB activation that mediates resistance to chemo- and radio-therapy. Therefore, the inhibition of NFB activity appears a potential therapeutic strategy for cancer treatment. In this review, we focus on the role of NFB in carcinogenesis and summarize actual inhibitors of NFB that could be potential therapeutic target in cancer therapy.
Appears in Collections:Translational Medicine @ UniSa. Vol.4 (sept.-dec. 2012)

Files in This Item:
There are no files associated with this item.
Show full item record SFX Query


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.